Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Management of children with multiple sclerosis.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.
Inhibition of autoimmune encephalomyelitis by a tetracycline.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Guillain-Barré syndrome in Colombia: where do we stand now?
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
Seeing optic neuritis through myopic eyes.
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Low dose naltrexone therapy in multiple sclerosis.

Pages